Appendix – 8th: 2018-2022
Primary Site | Histology | Year of Diagnosis |
---|---|---|
C181 | 8000-8149, 8154, 8160-8231, 8243-8248, 8250-8682, 8690-8700, 8720-8790 | 2018-2022 |
Notes
8000-8149, 8154, 8160-8231, 8243-8248, 8250-8682, 8690-8700, 8720-8790 C181 Appendix **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 19 *Appendix - Carcinoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** See the following schemas for the listed histologies * 8150-8153, 8155-8156, 8158, 8240-8242, 8249, 8683: *NET Appendix* * 8710-8714, 8800-8803, 8810-8921, 8932-8934, 8940-8990, 9000-9016, 9030-9043, 9045-9138, 9141-9230, 9240-9580, 9582: *Soft Tissue Abdomen and Thoracic* * 8804-8806, 8930-8931, 8991, 9020, 9044, 9231, 9581: *Soft Tissue Rare* * 8935-8936: *GIST* * 8992: *Soft Tissue Other* * 9140: *Kaposi Sarcoma* * 9700-9701: *Mycosis Fungoides*Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | Yes |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
Behavior | <BLANK> | No |
NAACCR #523
behaviorCodeIcdO3 |
None | |
Tumor Size Clinical | <BLANK> | No |
NAACCR #752
tumorSizeClinical |
None | |
Tumor Size Pathological | <BLANK> | No |
NAACCR #754
tumorSizePathologic |
None | |
Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
Regional Nodes Positive | <BLANK> | Yes |
NAACCR #820
regionalNodesPositive |
None | |
Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
LVI | 9 | No |
NAACCR #1182
lymphVascularInvasion |
None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | No |
NAACCR #1380
rxSummSurgRadSeq |
None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | No |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
EOD Regional Nodes | 999 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
SS2018 | <BLANK> | No |
NAACCR #764
summaryStage2018 |
None | |
Grade Clinical | 9 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
Grade Pathological | 9 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
Grade Post Therapy Clin (yc) | <BLANK> | Yes |
NAACCR #1068
gradePostTherapyClin |
All | SSDI |
Grade Post Therapy Path (yp) | <BLANK> | Yes |
NAACCR #3845
gradePostTherapy |
All | SSDI |
CEA PreTX Lab Value | XXXX.8 | No |
NAACCR #3820
ceaPretreatmentLabValue |
COC SEER |
SSDI |
CEA PreTX Interpretation | 8 | No |
NAACCR #3819
ceaPretreatmentInterpretation |
CCCR/Canada COC SEER |
SSDI |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Schema ID | 00190 |
NAACCR #3800
schemaId |
None | |
Derived Version | {{ctx_alg_version}} | None | None | |
Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None |